Angiogenic factors in moyamoya disease

Stroke

Volumn 27, Issue 12, 1996, Pages 2160-2165

  Yoshimoto, Tetsuyuki ^a   Houkin, Kiyohiro ^a   Takahashi, Akihiro ^a   Abe, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

angiogenesis; cytokines; moyamoya disease

Indexed keywords

ACETAZOLAMIDE; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOYAMOYA DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

EID: 0030469523     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.12.2160     Document Type: Article

References (32)

1. Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160:214-216.
2. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenetic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation. 1994;90:649-652.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267: 10931-10934.
4. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner WM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
5. Sato N, Beitz JG, Kato J, Yamamoto M, Clark JW, Calabresi P, Frackelton AR. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol. 1993;142:1119-1139.
6. Szekanecz Z, Shah MR, Harlow LA, Pearce WH, Koch AE. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. Pathobiology. 1994;62:134-139.
7. Hu DE, Fan TPD. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br J Pharmacol. 1995;114:262-268.
8. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun. 1992;189:824-831.
9. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela R, Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem. 1994;269:6271-6274.
10. Pepper MS, Vassalli JD, Orci L, Montesano R. Biphasic effect of transforming growth factor β1 on in vitro angiogenesis. Exp Cell Res. 1993;204:356-363.
11. Winkles LA, Gay CG. Serum phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin binding (acid and basic fibroblast growth factor) gene expression in human vascular smooth muscle cells. Cell Growth Differ. 1991;2:531-540.
12. Takahashi A, Kamiyama H, Houkin K, Abe H. Surgical treatment of childhood moyamoya disease: comparison between the reconstructive surgery centered on the frontal region and that centered on the parietal region. Neurol Med Chir (Tokyo). 1995;35:234-237.
13. Suzuki J, Takaku A. Cerebrovascular moyamoya disease: disease showing abnormal net-like vessels in the base of brain. Arch Neurol. 1969;20:288-299.
14. Kuroda S, Kamiyama H, Abe H, Houkin K, Isobe M, Mitsumori K. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid occlusion. Neurosurgery. 1993;32:912-919.
15. Ishikawa T, Houkin K, Abe H, Isobe M, Kamiyama H. Cerebral haemodynamics and long term prognosis after extra-cranial-intracranial bypass surgery. J Neurol Neurosurg Psychiatry. 1995;59: 625-628.
16. Baird A, Waliche PA. Fibroblast growth factors. Br Med Bull. 1989;45:438-452.
17. Gospodarowicz D. Isolation and characterization of acidic and basic growth factor. In: Methods in Enzymology, Peptide Growth Factors. Vol 147B. Orlando, Fla: Academic Press Inc; 1987:106-117.
18. Kiyota Y, Takami K, Iwane M, Shino A, Miyamoto M, Tsukuda R, Nagaoka A. Increase in basic fibroblast growth factor-like immunoreactivity in rat brain after forebrain ischemia. Brain Res. 1991; 545:322-328.
19. Schweigerer L, Neufeld G, Freidman J, Arabaham JA, Fiddes JC, Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature. 1989;325:209-221.
20. Gospodarowicz D, Ferrara N, Haaparanta T, Neufeld G. Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. Eur J Cell Biol. 1988;46:144-151.
21. Sueishi K, Kono S. Immunohistochemical localization of basic fibroblast growth factor in the narrowed arteries of the arteries of Willis in moyamoya disease. In: Fukui H, ed. 1992 Proceedings of the Research Committee on Spontaneous Occlusion of the Circle of Willis [in Japanese]. Tokyo, Japan: Ministry of Health and Welfare Japan. 1993:131-133.
22. Kono S, Oka K, Sueishi K. Histopathological and morphometric studies of leptomeningeal vessels in moyamoya disease. Stroke. 1990;21:1044-1050.
23. Masuda J, Ogata J, Yutani C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke. 1993;24:1960-1967.
24. Ogata J, Masuda J. Phenotype changes and proliferation of smooth muscle cells in occlusive arterial lesions in moyamoya disease. In: 1992 Proceedings of the Research Committee on Spontaneous Occlusion of the Circle of Willis [in Japanese]. Tokyo, Japan: Ministry of Health and Welfare Japan. 1993:131-133.
25. Oka K, Yamashita M, Sadoshima S, Tanaka K. Cerebral haemorrhage in moyamoya disease at autopsy. Virchows Arch. 1981;392A: 247-261.
26. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M. Possible roles of basic growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg. 1991; 75:267-270.
27. Houkin K, Tanaka N, Takahashi A, Kamiyama H, Abe H, Kajii N. Familial occurrence of moyamoya disease: magnetic resonance angiography as a screening test for high-risk subjects. Childs Nerv Syst. 1994;10:421-425.
28. Sunderketter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410-422.
29. Hu DE, Hori Y, Fan TPD. Interleukin-8 stimulates angiogenesis in rats. Inflammation. 1993;17:135-143.
30. Kubo H. Angiogenesis on encephalo-myo-synangiosis. Arch Jpn Chir. 1993;62:82-91.
31. Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K. Surgical treatment of moyamoya disease in pediatric patients: comparison between the results of indirect and direct revascularization procedures. Neurosurgery. 1992;31:401-405.
32. Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S. Surgical therapy for adult moyamoya disease: can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke. 1996; 27:1342-1346.